Bone metastasis and male sex are thought to be associated regardless of the presence/absence of EGFR gene mutations; however, further investigation of the tumor markers and pathological findings and the risk of bone and CNS metastases in postoperative EGFR‐positive NSCLC patients is needed. This evidence concerns the gene EGFR and neoplasm.